[1] Watt MJ, Miotto PM, De Nardo W, et al. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev,2019,40:1367-1393.
[2] Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol,2021,18:223-238.
[3] Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol 2021.
[4] Bijnen M, Josefs T, Cuijpers I, et al. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. Gut,2018,67:1317-1327.
[5] Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol, 2017,66:1300-1312.
[6] Gomez Perdiguero E, Klapproth K, Schulz C, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature,2015,518:547-551.
[7] Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol,2017,17:306-321.
[8] Lopez BG, Tsai MS, Baratta JL, et al. Characterization of Kupffer cells in livers of developing mice. Comp Hepatol,2011,10:2.
[9] Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity,2014,41:14-20.
[10] Zhang Y, Jiang W, Xu J, et al. E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization. Front Cell Infect Microbiol,2020,10:535940.
[11] Fan L, Lai R, Ma N, et al. miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder. J Hepatol,2021,74:8-19.
[12] Zhao Z, Zhong L, Li P, et al. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p. Exp Cell Res, 2020,387:111738.
[13] Zhang X, Fan L, Wu J, et al. Macrophage p38alpha promotes nutritional steatohepatitis through M1 polarization. J Hepatol,2019,71:163-174.
[14] Kong Q, Li N, Cheng H, et al. HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization. Diabetes, 2019,68:361-376.
[15] Jiang Q, Li Q, Liu B, et al. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-kappaB dependent macrophage polarization. Int Immunopharmacol,2021,96:107591.
[16] Handa P, Thomas S, Morgan-Stevenson V, et al. Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis. J Leukoc Biol,2019,105:1015-1026.
[17] Wan J, Benkdane M, Teixeira-Clerc F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology,2014,59:130-142.
[18] Han YH, Kim HJ, Na H, et al. RORalpha Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis. Cell Rep,2017,20:124-135.
[19] Xu F, Guo M, Huang W, et al. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol,2020,36:101634.
[20] Luo W, Xu Q, Wang Q, et al. Effect of modulation of PPAR-gamma activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep, 2017,7:44612.
[21] Feng J, Li L, Ou Z, et al. IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity. Cell Mol Immunol,2018,15:493-505.
[22] Zheng XL, Wu JP, Gong Y, et al. IL-25 protects against high-fat diet-induced hepatic steatosis in mice by inducing IL-25 and M2a macrophage production. Immunol Cell Biol, 2019,97:165-177.
[23] Chen G, Ni Y, Nagata N, et al. Lycopene Alleviates Obesity-Induced Inflammation and Insulin Resistance by Regulating M1/M2 Status of Macrophages. Mol Nutr Food Res, 2019,63:e1900602.
[24] Li Z, Feng PP, Zhao ZB, et al. Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway. Biochem Biophys Res Commun,2019,510:20-26.
[25] Chen G, Ni Y, Nagata N, et al. Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages. Lab Invest, 2019,99:1335-1348. |
